Nazca Capital Nears Aldous Bio Nutritionals Acquisition

Spanish private equity firm Nazca Capital is reportedly in exclusive negotiations to acquire a majority stake in Aldous Bio, a rapidly growing Spanish manufacturer of nutritional supplements. The deal, if finalized, would represent a significant investment in the burgeoning health and wellness sector, a market that has seen sustained expansion driven by increasing consumer focus on preventative health and well-being.

Aldous Bio, established in 2018 and based in Cuenca, has demonstrated impressive growth, with revenues reaching €22 million in the past fiscal year. Projections indicate that the company's EBITDA is on track to hit €6 million this year. The company's founder and CEO, Antonio Pellón, currently holds a commanding 95% ownership, with the remaining 5% held by KmZero, an innovation platform within the food sector backed by the Familia Martínez group. Market sources suggest the transaction could value the company at approximately €60 million, including debt.

The influx of capital from Nazca Capital is anticipated to fuel Aldous Bio's ambitious expansion plans. The company has outlined a strategic vision to reach €100 million in turnover by 2030. A key component of this strategy involves a €3.5 million investment in a new 4,000-square-meter manufacturing facility, slated for operation in 2027, which will significantly enhance production capacity to meet anticipated demand.

Aldous Bio's commercial success is largely attributed to its robust online presence, with e-commerce channels, particularly Amazon, accounting for 90% of its sales. While the company also operates its own direct-to-consumer website, it is strategically expanding its retail footprint into physical stores such as Druni, El Corte Inglés, and Decathlon, with plans to enter the pharmacy channel. This multi-channel approach is crucial for capturing a wider consumer base in the competitive nutraceutical market.

Geographically, Aldous Bio currently operates in Spain and Italy. However, the company is poised for international expansion, with immediate plans to enter markets including Portugal, France, Germany, and the United Kingdom within the current year. Further long-term ambitions include penetrating Asian markets and the United Arab Emirates. To support this global push, Aldous Bio is exploring the establishment of a dedicated logistics hub in the UK, signaling a serious commitment to international operations.

This potential acquisition aligns with Nazca Capital's established expertise in the consumer and health sectors. The firm already holds a significant position in the market through its ownership of Nutris, a manufacturer and distributor of functional gummies and raw ingredients. This prior experience provides Nazca Capital with valuable insights into the operational dynamics and growth drivers within the nutritional supplement industry, positioning them well to support Aldous Bio's next phase of development.